Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|July 13, 2021
Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003-2018): A nationwide population-based studyBrenda Leeneman, Kay Schreuder, Carin A Uyl-de Groot, et al.British Journal of Clinical Pharmacology|February 9, 2017
Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect?Linda G Franken, Anniek D Masman, Brenda C M de Winter, et al.International Journal of Radiation Oncology, Biology, Physics|November 22, 2011
A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapyIrene M Lips, Carla H van Gils, Alexis N T J Kotte, et al.European Journal of Clinical Pharmacology|July 7, 2017
Population pharmacokinetics of haloperidol in terminally ill adult patientsL G Franken, R A A Mathot, A D Masman, et al.Clinical Pharmacokinetics|December 31, 2015
Pharmacokinetics of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Terminally Ill Adult PatientsLinda G Franken, Anniek D Masman, Brenda C M de Winter, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 26, 2010
Long-term experience with transrectal and transperineal implantations of fiducial gold markers in the prostate for position verification in external beam radiotherapy; feasibility, toxicity and quality of lifeMaaike R Moman, Uulke A van der Heide, Alexis N T J Kotte, et al.British Journal of Clinical Pharmacology|September 30, 2017
Population pharmacodynamic modelling of midazolam induced sedation in terminally ill adult patientsLinda G Franken, Brenda C M de Winter, Anniek D Masman, et al.Expert Opinion on Drug Metabolism & Toxicology|April 16, 2016
Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidolL G Franken, B C M de Winter, H J van Esch, et al.European Journal of Drug Metabolism and Pharmacokinetics|April 20, 2022
A Population Pharmacokinetic Model of Whole-Blood and Intracellular Tacrolimus in Kidney Transplant RecipientsLinda G Franken, Marith I Francke, Louise M Andrews, et al.Trials|December 7, 2011
Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trialIrene M Lips, Uulke A van der Heide, Karin Haustermans, et al.Pageof 6